Horizon Therapeutics is focused on the development of prescription drugs for mild to moderate pain relief and arthritis. read more
Horizon Therapeutics Investor Relations Salary
The average Horizon Therapeutics Investor Relations earns an estimated $82,966 annually. Horizon Therapeutics' Investor Relations compensation is $1,036 more than the US average for a Investor Relations.
Last updated 3 years ago.
$35k
$47k
$63k
$70k
$109k
$139k
$168k
$82,966
Average Compensation
- $82,966
- avg. base
Investor Relations Salaries at Horizon Therapeutics
Compensation at Horizon Therapeutics by Department
How Investor Relations at Horizon Therapeutics Rate Their Compensation
The majority of Investor Relations at Horizon Therapeutics believe they're compensated fairly. 100% of Investor Relations at Horizon Therapeutics say they receive annual bonuses, and the vast majority (78%) are satisfied with their benefits. See more compensation ratings at Horizon Therapeutics
Investor Relations Salaries at Similar Size Companies
×